Latest filing published 10 Dec 2024 for Syngene International Limited, €76.5M.
Filing timeline
BuySaleBiocon Limited: trading record in brief
Biocon Limited is a declared insider of Syngene International Limited, with filings sourced from SEBI (PIT + SAST). The record holds 3 filings, for trades running from 6 September 2022 to 10 December 2024.
No open-market purchase appears, only 3 sales worth €482.7M. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 10 December 2024: an open-market sale of €76.5M, in Syngene International Limited. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Biocon Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000,000 shares@ ₹857.6815.9% of flowEquity SharesSEBI:57e4123aae4c2c8bd0756ffebeb2b288705b2536
- 40,000,000 shares@ ₹560.0052.2% of flowEquity SharesSEBI:e673ebde55006741a531a0f6ec3ae36361c0f6df
- 21,789,164 shares@ ₹560.035331.9% of flowEquity SharesSEBI:5d755f2a5bba2e3a9825cb3f021c6598e95f1752
3 of 3 declarations